Summary
President Donald Trump signed an executive order introducing tariffs of up to 100% on certain patented prescription drugs and their ingredients. Drug companies can avoid these tariffs by agreeing to lower prices and producing drugs in the U.S. The policy aims to reduce drug prices, but some worry it could increase costs instead.
Key Facts
- President Trump signed an order for tariffs on certain patented drugs and their ingredients, potentially up to 100%.
- Companies can avoid tariffs by entering pricing agreements and manufacturing in the U.S.
- Large companies have 120 days before the highest tariffs could apply; smaller companies have 180 days.
- The policy does not currently include generic drugs.
- It aims to lower U.S. drug prices by encouraging domestic production and price negotiations.
- The tariffs are framed as necessary for national security, according to a Commerce Department investigation.
- Certain countries, like those in the EU and Japan, will see lower tariffs due to existing trade deals.
- The plan is part of broader efforts to use tariffs specific to sectors after previous broad tariffs were deemed unlawful.
